Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026

Go back to Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
(NASDAQ: ZYME) Delayed: 23.21 +0.07 (0.30%)
Previous Close $23.14    52 Week High
Open $23.51    52 Week Low
Day High $23.62    P/E N/A 
Day Low $23.05    EPS
Volume 309,051